Loading clinical trials...
Loading clinical trials...
This is a Phase 2 open-label, multicenter, single-arm study evaluating the combination of Belvarafenib and Cobimetinib in patients with locally advanced or metastatic melanoma with NRAS mutations. The...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hanmi Pharmaceutical Company Limited
NCT07280832 · Unresectable Locally Advanced or Metastatic Melanoma
NCT05498792 · Locally Advanced or Metastatic Melanoma
NCT01783938 · Advanced or Metastatic Melanoma
NCT01864759 · Locally Advanced or Metastatic Melanoma
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do
Chonnam National University Hwasun Hospital
Hwasun, Jeollanam-do
Dong-A University Medical Center
Busan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions